Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lupin Albuterol MDI vs ProAir HFA in Mild Asthma
NCT02584257Phase 3Completed
- Sponsor
- Lupin Limited
- Start
- Apr 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salbutamol in asthma, sponsored by Lupin Limited. Primary endpoint: Post-dose PC20 Concentration. Started Apr 2016; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02584257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584257.